IL-27 Antibody (N-term) Blocking peptide
€363.00
In stock
SKU
AC-BP1707a
Background:
L27 is a cytokine that shares the sequence similarity with IL17. The treatment of endothelial cells with this cytokine has been shown to stimulate the production of other cytokines including IL6, IL8 and CSF2/ GM-CSF. The increased expression of IL8 induced by this cytokine was found to be NF-kappa B-dependent.
Other Names:
Interleukin-17D, IL-17D, Interleukin-27, IL-27, IL17D, IL27
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP1707a was selected from the N-term region of human L27 . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: IL17D
Gene ID: 53342
Primary Accession: Q8TAD2
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
L27 is a cytokine that shares the sequence similarity with IL17. The treatment of endothelial cells with this cytokine has been shown to stimulate the production of other cytokines including IL6, IL8 and CSF2/ GM-CSF. The increased expression of IL8 induced by this cytokine was found to be NF-kappa B-dependent.
Other Names:
Interleukin-17D, IL-17D, Interleukin-27, IL-27, IL17D, IL27
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP1707a was selected from the N-term region of human L27 . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: IL17D
Gene ID: 53342
Primary Accession: Q8TAD2
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review